Sinew Pharma Inc. (TPEX:6634)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
36.65
+1.65 (4.71%)
Apr 29, 2026, 1:44 PM CST
-18.56%
Market Cap 2.50B
Revenue (ttm) 47.00K
Net Income (ttm) -123.75M
Shares Out 71.29M
EPS (ttm) -1.74
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 68,442
Average Volume 126,741
Open 35.00
Previous Close 35.00
Day's Range 34.85 - 37.65
52-Week Range 29.05 - 56.50
Beta -0.04
RSI 55.27
Earnings Date Aug 13, 2026

About Sinew Pharma

Sinew Pharma Inc., a biopharmaceutical company, focuses on the research, development, and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases. The company’s products include SNP-610 drug, which is in Phase IIa clinical trial and SNP-630 drug, which is in Phase II clinical trial for treating patients with non-alcoholic steatohepatitis in Taiwan. It is also developing SNP-810 is in phase II clinical trial for use in pain relief and fever reduction; SNP-820 is in Phase II clinical trial for antidote for ac... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 57
Stock Exchange Taipei Exchange
Ticker Symbol 6634
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.